The urine albumin-to-creatinine ratio is associated with advanced cardiovascular-kidney-metabolic syndrome stages and mortality: an analysis of NHANES 1999–2018

Puntos clave

• Higher urine albumin-to-creatinine ratio is linked to increased mortality risk in advanced cardiovascular-kidney-metabolic syndrome stages.
• The study highlights a significant connection between elevated urine albumin-to-creatinine ratios and serious health outcomes such as cardiovascular disease.
• NHANES data analysis of participants from 1999 to 2018 supports the association of urine albumin-to-creatinine ratio with metabolic syndrome stages.
• Findings underscore the significance of monitoring kidney function through urine albumin-to-creatinine ratio for assessing health risks.